Boston Scientific manufactures medical devices that reach 44 million patients annually across 127 countries - cardiovascular stents, neurostimulators, endoscopes, and rhythm management systems that generate massive attack surfaces. The threat model is clear: compromised implantable devices, breached patient data at scale, and supply chain vulnerabilities spanning R&D to clinical deployment. With $1.68 billion in annual R&D spend and over 53,000 employees, the company operates a complex technical environment where device firmware, cloud infrastructure, and clinical networks intersect.
Security teams work across domains including embedded systems security for implantable devices, medical IoT infrastructure, regulatory compliance frameworks (FDA, GDPR, HIPAA), and third-party risk management across a global manufacturing footprint. The tech stack includes standard enterprise tooling - JIRA for workflow, Windchill for product lifecycle management, FPGA development for device hardware - but the real work involves securing proprietary device firmware, protecting clinical trial data, and hardening connections between implanted devices and external programming systems.
Founded in 1979 and headquartered in the US, Boston Scientific operates in heavily regulated territory where security failures have clinical consequences. Teams collaborate with healthcare professionals and regulatory bodies, requiring security practitioners who understand both technical controls and medical device compliance. The scale demands rigorous threat modeling: device tampering, ransomware targeting hospital integrations, and data exfiltration from clinical systems all sit within scope.
